Cutler Group LP Eagle Pharmaceuticals, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$44.58 - $52.6 $35,797 - $42,237	-803 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$45.82 - $56.9 $36,793 - $45,690	803 New	803 $40,000
Q2 2019 Aug 09, 2019	SELL	$46.61 - $58.45 $9,322 - $11,690	-200 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$36.72 - $67.73 $7,344 - $13,546	-200 Reduced 50.0%	200 $8,000
Q3 2018 Nov 07, 2018	BUY	$66.65 - $83.86 $6,665 - $8,386	100 Added 33.33%	400 $27,000
Q2 2018 Aug 10, 2018	SELL	$51.25 - $76.62 $5,125 - $7,662	-100 Reduced 25.0%	300 $22,000
Q1 2018 May 11, 2018	BUY	$52.16 - $66.86 $15,647 - $20,058	300 Added 300.0%	400 $21,000
Q4 2017 Jan 17, 2018	SELL	$49.6 - $60.87 $161,745 - $198,497	-3,261 Reduced 97.02%	100 $5,000
Q3 2017 Oct 17, 2017	BUY	$46.62 - $60.36 $156,689 - $202,869	3,361	3,361 $200,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.